mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.01 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.02 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.02 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.13 |
0.02 |